Moderna to cut 10% of global workforce as Covid shot sales drop 20%
Moderna is reducing its global workforce by around 10% by the end of 2025 as demand for Covid-19 vaccines continues to weaken….
Consumer spending in the US is slowing – Is the economy in trouble?
For two years, the American consumer has carried the economy. Even with interest rates at their highest level in two decades, spending…
Tata Motors’ $4.5B Iveco bid sends shares sliding: here’s why investors are wary
Tata Motors took a hit on Wednesday, with shares falling more than 4% after reports surfaced about a possible $4.5 billion bid…
Adidas shares slump after sales miss, tariff warning and guidance confirmation
Adidas shares tumbled on Wednesday after the German sportswear giant reported second-quarter sales below expectations and warned that new US tariffs would…
Dow Futures muted ahead of Fed decision: 5 things to know before Wall Street opens
Wall Street is heading into a high-stakes trading day on Wednesday with a sense of caution, as Dow Futures suggest a muted…
Visa stablecoin settlements top $200m as global adoption grows
Visa has crossed $200 million in cumulative stablecoin settlements, underscoring its commitment to blockchain integration amid rising demand for real-time digital payments….
UnitedHealth’s reinstated guidance hardly brings good news for UNH stock investors
UnitedHealth Group Inc (NYSE: UNH) has reinstated its full-year guidance, but the management’s estimates hardly brought any good news for investors. UnitedHealth…
Dow Futures trade mixed today: 5 things to know before Wall Street opens
Dow Futures were modestly higher early Monday, up by as much as 40 points before the open. The broader market is coming…
SoFi stock soars after blockbuster Q2 earnings: why analysts are calling it a ‘turning point’
SoFi stock got a strong reaction from investors this morning, with shares climbing over 10% in premarket trading. The company’s second-quarter results…
Sarepta shares soar 36% after FDA clears partial resumption of Elevidys shipments
Sarepta Therapeutics shares jumped over 36% in premarket trading on Tuesday after the company said it had received US Food and Drug…
